NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

Loop Capital Upgrades Shake Shack to Buy with Higher $127 Target

Loop Capital upgrades Shake Shack to Buy, raising its price target to $127. The firm says growth concerns are overstated and expects steady expansion and strong returns.

Loop Capital Upgrades Shake Shack to Buy with Higher $127 Target
Photo by Subhaan Saleem on Unsplash
Already have an account? Sign in.
Featured/ 11/14/2025 · 9:06 AM
SHAK
/ Read more

Feed↓

Anavex Faces Setback in European Alzheimer's Drug Approval
11/14/2025 · 8:44 AM

Anavex Faces Setback in European Alzheimer's Drug Approval

Anavex Life Sciences receives negative trend vote from EMA for blarcamesine Alzheimer's treatment but plans re-examination and continues FDA discussions.

/ Subscriber only
Bristol Myers & J&J Halt Key Heart Drug Trial After Weak Results
11/14/2025 · 8:20 AM

Bristol Myers & J&J Halt Key Heart Drug Trial After Weak Results

Bristol Myers Squibb and Johnson & Johnson have stopped a major Phase 3 trial of milvexian for acute coronary syndrome after an interim review showed the drug is unlikely to meet its main goals. Other trials continue with results expected in 2026.

/ Subscriber only
Avadel Gets Competing Bid from Lundbeck
11/14/2025 · 7:35 AM

Avadel Gets Competing Bid from Lundbeck

Avadel Pharmaceuticals receives unsolicited $23/share offer from Lundbeck, competing with existing $20/share Alkermes deal. Board reviewing superior proposal.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe